Cargando…
Effects of atorvastatin on biomarkers of acute kidney injury in amikacin recipients: A pilot, randomized, placebo-controlled, clinical trial
BACKGROUND: The most common clinical indication of aminoglycosides (AG) is the treatment of serious Gram-negative infections. The aim of this study was to evaluate plausible effects of atorvastatin on the biomarkers of acute kidney injury (AKI) in patients receiving amikacin. MATERIALS AND METHODS:...
Autores principales: | Heydari, Behrooz, Khalili, Hossein, Beigmohammadi, Mohammad-Taghi, Abdollahi, Alireza, Karimzadeh, Iman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393099/ https://www.ncbi.nlm.nih.gov/pubmed/28465698 http://dx.doi.org/10.4103/1735-1995.202150 |
Ejemplares similares
-
Atorvastatin for Prevention of Amikacin-induced Electrolytes Imbalances; a Randomized Clinical Trial
por: Heydari, Behrooz, et al.
Publicado: (2016) -
Clinical, Paraclinical, and Antimicrobial Resistance Features of Community-Acquired Acute Bacterial Meningitis at a Large Infectious Diseases Ward in Tehran, Iran
por: Heydari, Behrooz, et al.
Publicado: (2016) -
Infective endocarditis; report from a main referral teaching hospital in Iran
por: Heydari, Behrooz, et al.
Publicado: (2017) -
Clinical response and outcome of pneumonia due to multi-drug resistant Acinetobacter baumannii in critically ill patients
por: Shojaei, Lida, et al.
Publicado: (2016) -
The effect of zoledronic acid on hip geometry in renal transplant recipients: a double-blind placebo-controlled randomized study
por: Dabbaghmanesh, Alireza, et al.
Publicado: (2023)